# REtinal and VIsual Cortical Response in Early PSYchosis

> **NCT05167396** · NA · TERMINATED · sponsor: **Centre Psychothérapique de Nancy** · enrollment: 34 (actual)

## Conditions studied

- Prodromal Schizophrenia
- Psychotic Episode
- Prodromal Symptoms
- Healthy Controls

## Interventions

- **DEVICE:** Retinaute (BioSerenity)
- **DEVICE:** EEG Headset 64 electrodes (BioSemi)
- **DEVICE:** MonPackOne (Metrovision)

## Key facts

- **NCT ID:** NCT05167396
- **Lead sponsor:** Centre Psychothérapique de Nancy
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-26
- **Primary completion:** 2023-07-20
- **Final completion:** 2023-07-20
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Malfunctions of the Retinaute® but no adverse effects on participants. Study interrupted for BioSerenity to make technical corrections. Long immobilization of the device and conditions for reusing it not adapted to the continuation of the study.
- **Last updated:** 2024-08-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05167396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05167396, "REtinal and VIsual Cortical Response in Early PSYchosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05167396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*